BRIEF-Dish Bondholders Rejects Proposed Offer To Acquire DirecTV Which Is Contingent Upon Bondholders Accepting

BRIEF-Dish Bondholders Rejects Proposed Offer To Acquire DirecTV Which Is Contingent Upon Bondholders Accepting "Haircut" Of $1.5 Billion - Document Seen By Reuters

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Dish Bondholders Rejects Proposed Offer To Acquire DirecTV Which Is Contingent Upon Bondholders Accepting "Haircut" Of $1.5 Billion - Document Seen By Reuters

Nov 11, 2024 6:11 PM

Nov 11 (Reuters) -

* DISH BONDHOLDERS REJECTS PROPOSED OFFER TO ACQUIRE DIRECTV

WHICH

IS CONTINGENT UPON BONDHOLDERS ACCEPTING "HAIRCUT" OF $1.5

BILLION - DOCUMENT SEEN BY REUTERS

Source text:

Previous page： Finance guide could spur extra $200 billion for sustainable development, JPMorgan says Next page： --Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Finance guide could spur extra $200 billion for sustainable development, JPMorgan says

Oct 23, 2024

* Impact disclosure guidance released by Taskforce * Group chaired by JPMorgan ( JPM ), Natixis * Aims to help countries, companies raise impact finance By Karin Strohecker and Simon Jessop WASHINGTON, Oct 23 (Reuters) - A new guide for countries and companies seeking financing for activities that have a positive and verifiable social or environmental impact could unlock an...

--Mueller Water Products Increases Quarterly Dividend to $0.067 per Share From $0.064; Payable Nov. 20 to Shareholders of Record on Nov. 8

Oct 23, 2024

04:03 AM EDT, 10/23/2024 (MT Newswires) -- Price: 22.01, Change: -0.06, Percent Change: -0.27 ...

Alto Neuroscience Says Phase 2b Study in Major Depressive Disorder Fails to Meet Primary Endpoint

Oct 23, 2024

04:06 AM EDT, 10/23/2024 (MT Newswires) -- Alto Neuroscience ( ANRO ) said late Tuesday a phase 2b study of ALTO-100 in patients with major depressive disorder failed to meet its primary endpoint compared with placebo. Treatment with ALTO-100 did not demonstrate improvement in depressive symptoms compared to placebo in patients with a memory-based cognitive biomarker, Alto Neuroscience ( ANRO...

Synaptics Expands Taiwan Presence, Operations

Oct 23, 2024

03:57 AM EDT, 10/23/2024 (MT Newswires) -- Synaptics ( SYNA ) said late Tuesday it has expanded in the Taiwanese city of Hsinchu, making Taiwan the company's largest base of personnel worldwide. The company said the expansion gives it headroom to grow both its essential operations and engineering expertise. The facilities will house the team developing its AI-enabled devices for...